New Zealand markets closed

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
560.22+20.47 (+3.79%)
At close: 04:00PM EST
560.25 +0.03 (+0.01%)
After hours: 07:26PM EST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
7,032,000
7,725,000
6,375,000
3,696,000
2,938,000
Depreciation & amortisation
3,216,000
2,592,000
2,325,000
2,277,000
2,267,000
Deferred income taxes
-1,054,000
-647,000
-552,000
-302,000
-379,000
Stock-based compensation
309,000
230,000
196,000
181,000
181,000
Change in working capital
-2,395,000
-1,514,000
-299,000
-615,000
-477,000
Accounts receivable
-
-204,000
-1,302,000
-225,000
-366,000
Inventory
-
-1,065,000
-508,000
-458,000
-324,000
Accounts payable
-
479,000
59,000
266,000
201,000
Other working capital
5,600,000
6,789,000
6,815,000
4,047,000
3,785,000
Other non-cash items
663,000
156,000
244,000
34,000
13,000
Net cash provided by operating activities
8,124,000
9,312,000
8,289,000
4,973,000
4,543,000
Cash flows from investing activities
Investments in property, plant and equipment
-2,524,000
-2,523,000
-1,474,000
-926,000
-758,000
Acquisitions, net
-17,915,000
-19,395,000
-38,000
-1,843,000
-536,000
Other investing activities
84,000
-34,000
-6,000
118,000
-9,000
Net cash used for investing activities
-20,326,000
-21,932,000
-1,510,000
-1,487,000
-1,253,000
Cash flows from financing activities
Debt repayment
-12,996,000
-11,738,000
-1,100,000
-9,824,000
-7,306,000
Common stock issued
-
-
-
0
0
Common stock repurchased
-2,000,000
-2,000,000
-1,500,000
-1,500,000
-500,000
Dividends paid
-441,000
-395,000
-337,000
-297,000
-266,000
Other financing activities
-167,000
-91,000
-147,000
-69,000
-51,000
Net cash used provided by (used for) financing activities
3,266,000
6,581,000
959,000
-3,118,000
-2,237,000
Net change in cash
-9,114,000
-5,845,000
7,914,000
305,000
756,000
Cash at beginning of period
12,048,000
10,336,000
2,422,000
2,117,000
1,361,000
Cash at end of period
3,112,000
4,491,000
10,336,000
2,422,000
2,117,000
Free cash flow
Operating cash flow
8,124,000
9,312,000
8,289,000
4,973,000
4,543,000
Capital expenditure
-2,524,000
-2,523,000
-1,474,000
-926,000
-758,000
Free cash flow
5,600,000
6,789,000
6,815,000
4,047,000
3,785,000